Breaking news on mri pet scanning
Brain Imaging Improves Anxiety Treatment published
Fri, 09 May 2008 04:00:00 PDT
Wouldn't it be nice if our doctors could predict accurately whether we would respond to a particular medication? This question is important because research studies provide information about how groups of patients tend to respond to treatments, but inevitably, differences among groups of patients with the same diagnosis mean that findings about groups of patients may not apply to individuals from those groups.
Alternative To Biopsy For Women With Probably Benign Lesions published
Fri, 09 May 2008 03:00:00 PDT
Radiologists can, with confidence, recommend a six-month follow-up diagnostic mammogram rather than an immediate biopsy for patients with "probably benign" breast lesions, a new study emphasizes.The study found that six-month short-interval follow-up examinations had an 83% sensitivity, which is similar to the sensitivity of other diagnostic mammograms, said Erin J. Aiello Bowles, MPH, lead author of the study from the Group Health Center for Health Studies.
Magnetic Resonance Imaging Warms Up published
Fri, 09 May 2008 02:00:00 PDT
Standard magnetic resonance imaging, MRI, is a superb diagnostic tool but one that suffers from low sensitivity, requiring patients to remain motionless for long periods of time inside noisy, claustrophobic machines.
Volcano Corp Announces First Human Use Of The Volcano Optical Coherence Tomography (OCT) Imaging Catheter published
Fri, 09 May 2008 01:00:00 PDT
Volcano Corporation (NASDAQ: VOLC), a leading manufacturer and developer of intravascular ultrasound (IVUS), functional measurement (FM) and Optical Coherence Tomography (OCT) products designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced the first human procedure using the Volcano OCT Imaging catheter. The procedure was performed by Dr. Patrick Serruys at the Thoraxcenter, in Rotterdam, Netherlands.
Ultrasound First, Not CT, For Diagnosing Suspected Acute Appendicitis published
Fri, 09 May 2008 00:00:00 PDT
Color Doppler ultrasound, not CT, should be the first imaging examination for adult patients with suspected acute appendicitis, a new study emphasizes.The study of 420 medical records found that sonography correctly denied acute appendicitis in 303 of 312 adult patients, meaning it had a 97% specificity rate, said Diana Gaitini, MD, of Rambam Health Care Campus in Haifa, Israel.
Prostate Cancer Breakthrough Receives FDA Clearance published
Thu, 08 May 2008 02:00:00 PDT
A new imaging device, ei•Nav/Artemis™, now officially cleared by the U.S. Food and Drug Administration (FDA), offers urologists breakthrough technology that will significantly help in the fight against prostate cancer. Artemis, designed by Eigen, a Northern California-based company known for developing innovative, affordable medical imaging solutions, will be introduced at the American Urological Association's (AUA) annual meeting May 17 - 22 in Orlando, FL.
Aortic Aneurysm -- Often An Unexpected Diagnosis published
Thu, 08 May 2008 00:00:00 PDT
An aortic aneurysm can be a surprising, serious and unsettling diagnosis.Aortic aneurysms are frequently discovered at a routine exam -- through a CT scan or ultrasound of the abdomen, or an X-ray of the chest that's done for another purpose. Often, there are no symptoms, but aortic aneurysms can burst or tear without warning and cause life-threatening bleeding.The May issue of Mayo Clinic Health Letter provides an overview of this medical condition.
GE Healthcare Helping Women Lead Healthier Lives, Showcasing Latest Advancements At ACOG 2008 published
Wed, 07 May 2008 15:00:00 PDT
GE Healthcare is featuring its innovative technologies that can enable earlier detection, more accurate diagnoses of health conditions, and personalized treatment plans for women who are pregnant or affected by cancer, heart disease, osteoporosis, uterine fibroids and other conditions.
GE Healthcare Signs Global Molecular Diagnostic Agreement To Advance Respiratory Drug Development published
Wed, 07 May 2008 01:00:00 PDT
GE Healthcare, a subsidiary of the General Electric Company (NYSE:GE) announced that it has signed a non-exclusive agreement with Merck & Co., Inc. to share technology on imaging of the lungs that may help to advance respiratory treatment development.
GE Healthcare Introduces New 3.0T MR Scanner published
Tue, 06 May 2008 02:00:00 PDT
GE Healthcare announced it has received clearance from the U.S. Food and Drug Administration for the company's new 3.0T magnetic resonance (MR) scanner, the latest addition to GE's Signa family of MR systems. The new Signa® MR750 3.0T was introduced at the International Society of Magnetic Resonance in Medicine in Toronto, May 3-9.
Florida Senate Rejects Measure Requiring Ultrasounds Before Abortion At Any Stage published
Mon, 05 May 2008 09:00:00 PDT
Florida's Republican-controlled Senate voted 20-20 to reject a House-approved bill (SB 2400) on Wednesday that would have required physicians to perform an ultrasound on all women seeking abortion, the Miami Herald reports.
Healthcare Providers Demand Feedback About Computed Radiography published
Mon, 05 May 2008 04:00:00 PDT
KLAS investigates single-cassette, also known as single-plate, computed radiography (CR) in this groundbreaking study, as a result of healthcare provider demand for feedback on direct user experiences with CR systems and vendors. CR equipment is a sizable market as a result of PACS technology and the possible prohibitive costs associated with digital radiography (DR) systems. Nearly 60 percent of the images acquired in hospitals come from x-ray.
Imaging Yields Insights Into 'Nanomedicine' For Cancer Treatment published
Mon, 05 May 2008 00:00:00 PDT
Researchers at Purdue University have discovered a possible new pathway for anti-tumor drugs to kill cancer cells and proposed how to improve the design of tiny drug-delivery particles for use in "nanomedicine." The synthetic "polymer micelles" are drug-delivery spheres 60-100 nanometers in diameter, or roughly 100 times smaller than a red blood cell. The spheres harbor drugs in their inner core and contain an outer shell made of a material called polyethylene glycol.
US Oncology Applauds Journal Of Clinical Oncology Study Highlighting Value Of PET Scans For Cancer Patients With Various Types Of Malignancies published
Fri, 02 May 2008 00:00:00 PDT
US Oncology, which supports one of the nation's largest cancer treatment and research networks representing approximately 1,200 oncologists nationwide, applauded a national study appearing in today's Journal of Clinical Oncology (JCO) that demonstrates the value of positron emission tomography (PET) scans for treating patients with ovarian, prostate, pancreatic and other types of cancers.
Effects Of Rimonabant On Cardiometabolic Risk Profile Include Loss Of Visceral Fat And Mobilization Of Liver Fat published
Wed, 30 Apr 2008 01:00:00 PDT
At a late breaking presentation made on April 29th during the Annual meeting of the European Atherosclerosis Society held in Istanbul, the investigators of ADAGIO-LIPIDS presented the key findings of a one year trial aiming at further studying the effects of rimonabant on several features of HDL and on a comprehensive set of cardiometabolic markers.
Acusphere Submits New Drug Application For FDA Approval Of Imagify(TM) published
Wed, 30 Apr 2008 01:00:00 PDT
Acusphere Inc. (NASDAQ: ACUS) announced the submission of a New Drug Application (NDA) to the U.S. Food & Drug Administration (FDA) for approval to market its lead product candidate, Imagify™ (Perflubutane Polymer Microspheres for Injectable Suspension). Imagify is an ultrasound imaging agent for the detection of coronary artery disease, the leading cause of death in the United States.
European Ultrasound Markets Embrace New Technologies published
Wed, 30 Apr 2008 01:00:00 PDT
Advancements in obstetrics and gynaecology ultrasound, hand-carried ultrasound as well as other smaller market segments such as urology and surgical ultrasound are driving the European ultrasound market. New analysis from Frost & Sullivan, European Markets for Ultrasound, finds that the market was worth $0.9 billion in 2007 and estimates this to reach $1.4 billion in 2014.
Community Breast Center Experience Shows Real World Application Of Breast-Specific Gamma Imaging Has Significant Impact On Clinical Care published
Wed, 30 Apr 2008 00:00:00 PDT
Recently published data in The American Journal of Surgery by a group of surgeons from Legacy Good Samaritan Hospital in Portland, Oregon, demonstrates the value of using Breast-Specific Gamma Imaging (BSGI) for the clinical management of breast cancer patients.
Cell Phones Used To Increase Access To Medical Imaging published
Tue, 29 Apr 2008 20:00:00 PDT
An article published in the open-access journal PLoS Onedescribes a new technique that uses cell phones for medical imagingpurposes. According to the authors, the new technology, developed byengineers at the University of California, Berkeley, couldimprovethe accessibility of medical imaging to billions of people aroundthe world.
Neuroimaging Improves Quality Of Life For Brain Tumor Patients published
Mon, 28 Apr 2008 00:00:00 PDT
A new neuroimaging study at the Montreal Neurological Institute and Hospital at McGill University aims to ensure the highest quality of life for patients by assessing their cognitive skills before, during, and after brain tumour surgery. This is done by mapping the important functional brain areas surrounding the tumour in order to decrease the risks during surgery.
Headset Muffles Loud, Unnerving MRI Noises published
Sat, 26 Apr 2008 02:00:00 PDT
Having an MRI exam, an experience many people describe as stressful and uncomfortable, could soon become a bit more pleasant, thanks to the work of a team of University of Florida engineering students.The students have designed a headset that shows promise of reducing the extremely loud, repetitive, industrial-like noises that accompany magnetic resonance image examinations.
Positive Results From Re-Read Of Vasovist(R) Phase 3 Images Announced By EPIX Pharmaceuticals published
Thu, 24 Apr 2008 02:00:00 PDT
EPIX Pharmaceuticals, Inc. (NASDAQ:EPIX), a biopharmaceutical company focused on discovering and developing novel therapeutics through the use of its proprietary and highly efficient in silico drug discovery platform, announced today it has achieved positive results from the blinded, independent re-read of images of its novel blood pool magnetic resonance angiographic (MRA) agent, Vasovist (gadofosveset trisodium).
Royal Surrey County Hospital Installs UK's First Ceiling-mounted Artis Zee - Siemens Innovation Increases Flexibility In Interventional Suite published
Wed, 23 Apr 2008 15:00:00 PDT
Royal Surrey County Hospital, a principal District General Hospital serving the Surrey community, has installed the first ceiling-mounted Artis zee from Siemens in the UK. The new system replaces a 13 year old interventional setup. DynaCT and syngo iPilot and iGuide needle guidance applications have been installed with the Artis zee to offer a comprehensive imaging solution for oncology, angiography and interventional procedures.
MRI Equipment Market To Reach 5.5 Billion Dollars By 2010, According To New Report By Global Industry Analysts, Inc. published
Wed, 23 Apr 2008 01:00:00 PDT
Since the introduction of magnetic resonance imaging (MRI), the technology has become a ubiquitous diagnostic tool for better understanding of diseases. A trade-off between patient-comfort designs and enhanced diagnostic information highlights the trend in modern MRI equipment research. In this highly sophisticated industry, innovation and service quality are the trump cards of success. Image quality remains the impulse for equipment selection.
S.C. Legislature Approves Abortion Ultrasound Measure published
Tue, 22 Apr 2008 07:00:00 PDT
The South Carolina Legislature on Thursday approved a bill (S 84) that would require abortion providers to ask women seeking abortions whether they want to see ultrasound images of the fetus before undergoing the procedure, the
)
|
|
